Low-energy differential target multiplexed SCS derivative reduces pain and improves quality of life through 12 months in patients with chronic back and/or leg pain.
Peacock J, Provenzano D, Fishman M, Amirdelfan K, Bromberg T, Schmidt T, White T, Grewal P, Justiz R, Calodney A, El-Naggar A, Shah B, Esposito M, Gatzinsky K, Kallewaard JW, Poree L, Cleland A, Rice C, Theis E, Noel K, LaRue M.
Peacock J, et al. Among authors: esposito m.
Pain Pract. 2024 Sep 11. doi: 10.1111/papr.13407. Online ahead of print.
Pain Pract. 2024.
PMID: 39258956